Qiagen Receives FDA Clearance for First Mini Gastrointestinal Panel

Qiagen received FDA clearance for its new QIAstat-Dx mini gastrointestinal panel last week.

According to Qiagen, the test is the first in a series of QIAstat-Dx gastrointestinal (GI) panel tests for clinical use.

The new QIAstat-Dx Gastrointestinal Panel 2 mini B&V (bacterial and viral) is designed for the rapid outpatient diagnosis of gastrointestinal conditions.